Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

2.0K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.0K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

998
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
998
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

496
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
496
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

1.0K
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.0K
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

561
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
561
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

382
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
382

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peer Review and AI: Your (Human) Opinion Is What Matters.

ACS nano·2026
Same author

Smart Catheters for Diagnosis, Monitoring, and Therapy.

Advanced healthcare materials·2025
Same author

Liver Transplant Anatomy: Basics for Interventional Radiologists.

Seminars in interventional radiology·2025
Same author

Ionic Liquid-Reinforced Multifunctional Hydrogel for the Treatment of Enterocutaneous Fistula.

Advanced materials (Deerfield Beach, Fla.)·2025
Same author

Catheter Injectable Multifunctional Biomaterial for the Treatment of Infected Enterocutaneous Fistulas.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

A soft thermal sensor for the continuous assessment of flow in vascular access.

Nature communications·2025

Related Experiment Video

Updated: Feb 15, 2026

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

2.1K

Hemodialysis access thrombosis.

Keith Bertram Quencer1, Rahmi Oklu2

  • 1Division of Interventional Radiology, Department of Radiology, University of Utah, Salt Lake City, UT, USA.

Cardiovascular Diagnosis and Therapy
|February 6, 2018
PubMed
Summary
This summary is machine-generated.

Arteriovenous (AV) access thrombosis is a major complication for hemodialysis patients, often leading to lost access. Percutaneous declotting methods offer alternatives to surgery for managing AV access thrombosis.

Keywords:
AV access thrombosisArteriovenous fistula (AVF)arteriovenous graft (AVG)pulse spray aided pharmacomechanical thrombolysis

More Related Videos

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
04:36

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis

Published on: October 2, 2020

2.7K
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

3.3K

Related Experiment Videos

Last Updated: Feb 15, 2026

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

2.1K
Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
04:36

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis

Published on: October 2, 2020

2.7K
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

3.3K

Area of Science:

  • Nephrology
  • Vascular Surgery
  • Interventional Radiology

Background:

  • Over 400,000 patients in the US rely on hemodialysis.
  • Arteriovenous (AV) access thrombosis is a common and serious complication.
  • Thrombosis leads to missed dialysis, hospitalizations, and permanent access loss.

Purpose of the Study:

  • To review the current percutaneous treatment options for AV access thrombosis.
  • To highlight the advantages of percutaneous methods over surgical thrombectomy.

Main Methods:

  • Review of existing literature on percutaneous declotting techniques.
  • Comparison of different percutaneous approaches: lyse-and-wait, thromboaspiration, pulse spray, and mechanical thrombectomy devices.

Main Results:

  • Percutaneous declotting is the preferred method for AV access thrombosis.
  • Multiple percutaneous techniques are available, each with potential benefits.
  • These methods aim to restore AV access patency and prevent permanent loss.

Conclusions:

  • Percutaneous declotting offers effective management for AV access thrombosis in hemodialysis patients.
  • A range of percutaneous techniques allows for tailored treatment strategies.
  • Minimizing complications like missed dialysis and access loss is crucial for patient care.